Navigation Links
Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC
Date:7/21/2014

sms and Psychiatric Disorders: A HuGE Review state: "Our main finding was that the MTHFR C677T polymorphism is associated with major depression, schizophrenia, and bipolar disorder. The magnitudes of the associations were moderate but statistically significant."

Folate therapy is recommended by both the American Psychiatric Association and the APA Task Force on Complementary and Alternative Medicine as a safe, effective option in depression with a favorable side effect profile. EnLyte is an advanced folate therapy used in the treatment of depression and hyperhomocysteinemia, with a pregnancy category A rating, that is gaining much attention and support in the Psychiatric community. Because it contains highly refined and metabolized folates and cofactors, it bypasses the MTHFR mutation, and others common in mood disorders. To assess it's effectiveness in sleep, Dr. Arnold Mech, MD of Mech HealthCare Associates, performed an open label study of EnLyte on sleep quality. According to Dr. Mech, 70% of patients with mood symptoms have a form of MTHFR, leaving them less able to efficiently convert folate (vitamin B9) and other B vitamins to their methylated, reduced form necessary for use in the production of neurotransmitters.

EnLyte was added to the treatment regimen for 4 weeks of 60 patients who had tested positive for one or two C677T allele MTHFR polymorphisms. Pre and post-EnLyte levels of fatigue were obtained per standard clinic protocol using the Fatigue Assessment Scale (FAS) and levels of emotional dysregulation (difficulties in frustration tolerance and impulse control) with the Mech Emotional Dysregulation Inventory (MEDI). At the end of the 4 weeks, most patients reported their sleep was significantly impr
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. IROA Technologies automates metabolic profiling with launch of labeling and software kits
2. The Holistic Sanctuary Responds to Johnson & Johnson’s Guilty Plea for Selling Risperdal Off-Label
3. Public wants labels for food nanotech -- and theyre willing to pay for it
4. Z Trim to Present at the 2013 Clean Label Conference
5. Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks
6. Lilly and Incyte Announce Baricitinib Efficacy and Safety Data from the Open-Label, Long-Term Extension of the Phase 2b JADA Study in Patients with Rheumatoid Arthritis
7. Z Trim Helps Food Manufacturers "Clean" Their Labels - Replace Chemically Modified Foods With "Corn Fiber"
8. Grandevo® Bioinsecticide Removes Bee Warning from Label
9. Despite Lucentiss Recent Expanded Label for Diabetic Macular Edema, Avastin Remains the Preferred Intravitreal Therapy for Diabetic Macular Edema in the United States
10. Clearbridge BioMedics Reveals ClearCell(R) FX, Next Generation Label-free Cancer Cell Enrichment System at ASCO 2013
11. ISPE Releases New Guidance for Standardizing Use of Booklet Labels in Global Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... SAN DIEGO , May 1, 2015 /PRNewswire/ ... biotechnology company engaged in the development of biosimilar ... proteins, announced today that its first quarter 2015 ... 14, 2015, before the open of market. At 8:30 ... conference call to discuss the financial results and ...
(Date:5/1/2015)... May 1, 2015 Albany Molecular Research Inc. ... S. Marth , AMRI,s President and Chief Executive Officer, ... 2015 Health Care Conference on Wednesday, May 13, 2015 ... webcast of the presentation can be accessed at AMRI,s ... The webcast will be archived for 90 days ...
(Date:4/30/2015)... April 30, 2015  Roka Bioscience, Inc. (NASDAQ: ... advanced testing solutions for the detection of foodborne pathogens, ... first quarter of 2015 on May 7, 2015 after ... Bioscience will also host a conference call at 4:30 ... its first quarter financial results. During the conference call, ...
(Date:4/30/2015)... 2015 Nitto Avecia, a leading ... increased capacity and production capability to serve biotechnology ... and service fulfillment continues to drive Nitto Avecia ... throughput capacities. , In Fall 2014, ... process equipment at its Milford, MA facility, which ...
Breaking Biology Technology:Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2Roka Bioscience to Report First Quarter 2015 Financial Results On May 7, 2015 2Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2
... Pearl Therapeutics, Inc.,a biopharmaceutical company developing treatments ... Colin Reisner, MD, FCCP,FAAAAI to the position of ... Development and Medical Affairs, and Michael Golden,to the ... "We are delighted to welcome Colin and ...
... New Clinical Trial Sites Recently Initiated To Support Ongoing ... Trials-, ... Including Four Phase II Trials in Major Disease Indications-, -Revenues Plus Cash On-Hand ... Advance ...
... HONG KONG, Dec. 20 /Xinhua-PRNewswire-FirstCall/ -- China Technology,Development ... a,provider of clean and renewable energy products and ... announced that it has completed,another step in its ... resources on the principal business of solar energy., ...
Cached Biology Technology:Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs 2Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs 3Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 2Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 3Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 4Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 5CTDC Announces the Disposal of Non-core Business 2
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. today ... (FIDO ® ) Alliance tm , an industry ... members commit to share technology and collaborate to ... are interoperable, more secure and private, and easier ... identity verification that protects sensitive user information and ...
(Date:4/13/2015)... 2015  higi, a leading cloud-based consumer engagement platform ... engage with their communities around health and wellness, announced ... secure API.  ... affordable, and convenient vehicle to receive validated health information ... The API will allow higi,s trusted partners, on ...
(Date:4/8/2015)... 2015  Infinisource, a leading provider of SaaS-based Human ... a leading supplier of biometric identification and security ... most advanced biometrically-enabled time clock, the companies announced ... is setting a bold, new standard for the ... small and mid-size employer. When connected to the ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... time in a restful state akin to hibernation rather than ... in cells, new research suggests. And instead of being ... restful period appears to be a programmed step for RNA ... cell division and decide where proteins will work in a ...
... Leuven scientists (VIB/KU Leuven) are using zebrafish as a model ... the mechanism of amyotrophic lateral sclerosis (ALS). As a result, ... for a future ALS treatment. ALS is a progressive degenerative ... Their study has been published in the prestigious journal ...
... have long been appreciated, but now scientists at Duke ... makes mother,s milk better than infant formula in protecting ... in the August issue of the journal Current ... but not infant formula, fosters colonies of microbiotic flora ...
Cached Biology News:To cap or not to cap: Scientists find new RNA phenomenon that challenges dogma 2To cap or not to cap: Scientists find new RNA phenomenon that challenges dogma 3To cap or not to cap: Scientists find new RNA phenomenon that challenges dogma 4Zebra fish point the way towards new therapies for amyotrophic lateral sclerosis 2Breast milk promotes a different gut flora growth than infant formulas 2Breast milk promotes a different gut flora growth than infant formulas 3
...
...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Chicken polyclonal to QPRT ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to Internal sequence amino acids 123-237 of Human QPRT Entrez Gene ID: 23475 ...
Biology Products: